Magnera (MAGN) Proxy filing summary
Event summary combining transcript, slides, and related documents.
Proxy filing summary
14 Jan, 2026Executive summary
Annual meeting scheduled for March 9, 2026, with voting on director elections, auditor ratification, and executive compensation approval.
Company completed a major merger in November 2024, forming a new entity with 8,500 employees and $3.2B in revenue for FY2025.
Proxy materials and annual report are available online; shareholders of record as of December 31, 2025, are eligible to vote.
Voting matters and shareholder proposals
Shareholders will vote to elect nine directors for one-year terms, ratify Ernst & Young LLP as auditor, and approve executive compensation on an advisory basis.
Board recommends voting FOR all proposals.
Proxy access allows eligible shareholders to nominate directors in the proxy statement.
Board of directors and corporate governance
Board consists of nine members, majority independent, with an independent non-executive chair.
Committees: Audit, Compensation, and Nominating & Corporate Governance, all comprised of independent directors.
Annual board and committee self-assessments, director education, and majority voting standard for director elections.
No shareholder rights plan; shareholders can call special meetings.
Latest events from Magnera
- All proposals passed, directors elected, and no shareholder questions were raised.MAGN
AGM 20269 Mar 2026 - Net sales up 13% to $792M, adjusted EBITDA up 11%, and 2026 guidance reaffirmed.MAGN
Q1 20265 Feb 2026 - Votes on directors, auditor ratification, and executive pay are set for the 2026 meeting.MAGN
Proxy filing14 Jan 2026 - Q1 sales rose 35% to $702M post-merger, with EBITDA up 8% and widened losses from integration costs.MAGN
Q1 202523 Dec 2025 - Strong Q4, raised 2026 outlook, and innovation drive global growth and operational excellence.MAGN
BofA Securities Leveraged Finance Conference 20253 Dec 2025 - Net sales hit $839M, EBITDA $91M; merger and cost initiatives offset market softness.MAGN
Q3 202523 Nov 2025 - Q2 sales up 48% to $824M on merger, but net loss and lower EBITDA guidance issued.MAGN
Q2 202521 Nov 2025 - 2026 EBITDA to rise 9% on synergies, with robust cash flow and improved leverage.MAGN
Q4 202520 Nov 2025 - Synergy realization and operational optimization drive growth and margin recovery into 2027.MAGN
Wells Fargo Industrials & Materials Conference 202510 Nov 2025